PMID- 36137411 OWN - NLM STAT- MEDLINE DCOM- 20221018 LR - 20231213 IS - 2352-3964 (Electronic) IS - 2352-3964 (Linking) VI - 84 DP - 2022 Oct TI - Dermal thirdhand smoke exposure induces oxidative damage, initiates skin inflammatory markers, and adversely alters the human plasma proteome. PG - 104256 LID - S2352-3964(22)00438-8 [pii] LID - 10.1016/j.ebiom.2022.104256 [doi] LID - 104256 AB - BACKGROUND: Thirdhand smoke (THS) exposure correlated with significant metabolism of carcinogenic chemicals and the potential to cause detrimental health effects. Human harm research of THS exposure is limited to one other study and overall, there is a general lack of knowledge of the human health responses to THS exposure. METHODS: This was a clinical investigation to evaluate the health effects of 3-h dermal THS exposure from urine and plasma. 10 healthy, non-smoking subjects were recruited for dermal exposure for 3 h exposed to clothing impregnated with filtered clean air or THS. Exposures to clean air or THS occurred 20-30 days apart. FINDINGS: In THS-exposed group, there was a significant elevation of urinary 8-OHdG, 8-isoprostane, protein carbonyls. The THS 3-h exposure identified proteomics pathways of inflammatory response (p=2.18 x 10(-8)), adhesion of blood cells (p=2.23 x 10(-8)), atherosclerosis (p=2.78 x 10(-9)), and lichen planus (p=1.77 x 10(-8)). Nine canonical pathways were significantly activated including leukocyte extravasation signaling (z-score=3.0), and production of nitric oxide and reactive oxygen in macrophages (z-score=2.1). The THS 22-h proteomics pathways revealed inflammation of organ (p=3.09 x 10(-8)), keratinization of the epidermis (p=4.0 x 10(-7)), plaque psoriasis (p=5.31 x 10(-7)), and dermatitis (p=6.0 x 10(-7)). Two activated canonical pathways were production of nitric oxide and reactive oxygen in macrophages (z-score=2.646), and IL-8 signaling (z-score=2.0). INTERPRETATION: This is a clinical study demonstrating that acute dermal exposure to THS mimics the harmful effects of cigarette smoking, alters the human plasma proteome, initiates mechanisms of skin inflammatory disease, and elevates urinary biomarkers of oxidative harm. FUNDING: Funding was provided by the Tobacco Related Disease Research Program (TRDRP) 24RT-0037 TRDRP, 24RT-0039 TRDRP, and 28PT-0081 TRDRP. CI - Copyright (c) 2022. Published by Elsevier B.V. FAU - Sakamaki-Ching, Shane AU - Sakamaki-Ching S AD - Department of Molecular, Cell, and Systems Biology, University of California, Riverside, United States. FAU - Schick, Suzaynn AU - Schick S AD - Center for Tobacco Control Research and Education, University of California, San Francisco, United States. FAU - Grigorean, Gabriela AU - Grigorean G AD - Proteomics Core Facility, University of California, Davis, United States. FAU - Li, Jun AU - Li J AD - Department of Statistics, University of California, Riverside, United States. FAU - Talbot, Prue AU - Talbot P AD - Department of Molecular, Cell, and Systems Biology, University of California, Riverside, United States. Electronic address: talbot@ucr.edu. LA - eng PT - Journal Article DEP - 20220919 PL - Netherlands TA - EBioMedicine JT - EBioMedicine JID - 101647039 RN - 0 (Biomarkers) RN - 0 (Interleukin-8) RN - 0 (Proteome) RN - 0 (Tobacco Smoke Pollution) RN - 31C4KY9ESH (Nitric Oxide) RN - S88TT14065 (Oxygen) SB - IM MH - Biomarkers MH - Humans MH - Interleukin-8 MH - Nitric Oxide/pharmacology MH - Oxidative Stress MH - Oxygen MH - Proteome MH - Nicotiana MH - *Tobacco Smoke Pollution/adverse effects PMC - PMC9494172 OTO - NOTNLM OT - Biomarkers OT - Inflammation OT - Oxidative stress OT - Proteomics OT - Skin disease OT - Thirdhand smoke COIS- Declaration of interests The authors did not receive direct funding for this project. Funding from TRDRP was administered via the institution. All authors declare no direct support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work. EDAT- 2022/09/23 06:00 MHDA- 2022/10/19 06:00 PMCR- 2022/09/19 CRDT- 2022/09/22 18:20 PHST- 2022/03/02 00:00 [received] PHST- 2022/07/16 00:00 [revised] PHST- 2022/08/22 00:00 [accepted] PHST- 2022/09/23 06:00 [pubmed] PHST- 2022/10/19 06:00 [medline] PHST- 2022/09/22 18:20 [entrez] PHST- 2022/09/19 00:00 [pmc-release] AID - S2352-3964(22)00438-8 [pii] AID - 104256 [pii] AID - 10.1016/j.ebiom.2022.104256 [doi] PST - ppublish SO - EBioMedicine. 2022 Oct;84:104256. doi: 10.1016/j.ebiom.2022.104256. Epub 2022 Sep 19.